Personalis, Inc. (PSNL)

USD 4.16

(7.77%)

Long Term Debt Summary of Personalis, Inc.

  • Personalis, Inc.'s latest annual long term debt in 2023 was 1.23 Million USD , down -96.99% from previous year.
  • Personalis, Inc.'s latest quarterly long term debt in 2024 Q1 was 925 Thousand USD , down -25.04% from previous quarter.
  • Personalis, Inc. reported annual long term debt of 41.04 Million USD in 2022, down -22.27% from previous year.
  • Personalis, Inc. reported annual long term debt of 52.79 Million USD in 2021, up 518.16% from previous year.
  • Personalis, Inc. reported quarterly long term debt of 925 Thousand USD for 2024 Q1, down -25.04% from previous quarter.
  • Personalis, Inc. reported quarterly long term debt of 40.69 Million USD for 2023 Q1, down -0.84% from previous quarter.

Annual Long Term Debt Chart of Personalis, Inc. (2023 - 2017)

Historical Annual Long Term Debt of Personalis, Inc. (2023 - 2017)

Year Long Term Debt Long Term Debt Growth
2023 1.23 Million USD -96.99%
2022 41.04 Million USD -22.27%
2021 52.79 Million USD 518.16%
2020 8.54 Million USD 1236.62%
2019 639 Thousand USD -6.44%
2018 683 Thousand USD 133.9%
2017 292 Thousand USD 0.0%

Peer Long Term Debt Comparison of Personalis, Inc.

Name Long Term Debt Long Term Debt Difference
Aclaris Therapeutics, Inc. 3.07 Million USD 59.857%
Biodesix, Inc. 35.22 Million USD 96.497%
bioAffinity Technologies, Inc. 1.11 Million USD -10.329%
Castle Biosciences, Inc. 14.19 Million USD 91.309%
DarioHealth Corp. 24.59 Million USD 94.982%
Exact Sciences Corporation 2.47 Billion USD 99.95%
IDEXX Laboratories, Inc. 622.88 Million USD 99.802%
Illumina, Inc. 1.48 Billion USD 99.917%
Intelligent Bio Solutions Inc. 81.32 Thousand USD -1417.387%
iSpecimen Inc. 29.13 Thousand USD -4136.183%
Standard BioTools Inc. 3.98 Million USD 69.018%
23andMe Holding Co. 67.84 Million USD 98.181%
Medpace Holdings, Inc. 142.12 Million USD 99.132%
NeoGenomics, Inc. 606.06 Million USD 99.796%
Inotiv, Inc. 399.4 Million USD 99.691%
Psychemedics Corporation 945 Thousand USD -30.582%
Prenetics Global Limited 867.21 Thousand USD -42.295%
Precipio, Inc. 106 Thousand USD -1064.151%
RadNet, Inc. 812.06 Million USD 99.848%
Sotera Health Company 2.22 Billion USD 99.945%
Star Equity Holdings, Inc. 1.14 Million USD -7.773%
Exagen Inc. 19.23 Million USD 93.583%
Natera, Inc. 282.94 Million USD 99.564%
Aspira Women's Health Inc. 1.43 Million USD 13.706%
Neogen Corporation 888.39 Million USD 99.861%
Myriad Genetics, Inc. 130.9 Million USD 99.057%
ICON Public Limited Company 3.66 Billion USD 99.966%
Bionano Genomics, Inc. 7.17 Million USD 82.801%
CareDx, Inc 28.27 Million USD 95.636%
Check-Cap Ltd. - USD -Infinity%
Twist Bioscience Corporation 79.17 Million USD 98.441%
Guardant Health, Inc. 1.13 Billion USD 99.892%
BioNexus Gene Lab Corp. 98.76 Thousand USD -1149.456%
Fulgent Genetics, Inc. 10.11 Million USD 87.795%
Sera Prognostics, Inc. 840 Thousand USD -46.905%
OPKO Health, Inc. 222.03 Million USD 99.444%
Applied DNA Sciences, Inc. 739.16 Thousand USD -66.946%
Star Equity Holdings, Inc. 1.14 Million USD -7.773%
MDxHealth SA 35.56 Million USD 96.53%
Prenetics Global Limited 867.21 Thousand USD -42.295%
ENDRA Life Sciences Inc. 192.06 Thousand USD -542.501%
Mainz Biomed B.V. 2.19 Million USD 43.804%
Trinity Biotech plc 54.65 Million USD 97.742%
Neuronetics, Inc. 59.28 Million USD 97.918%
bioAffinity Technologies, Inc. 1.11 Million USD -10.329%